Anti-apoptotic proteins like Bcl-2, Bcl-xL, and Mcl-1 are often overexpressed in glioblastoma, allowing cellular proliferation and the resistance of tumor cells to various therapies [57]. This evidence concerns the gene MCL1 and glioblastoma.